Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A novel composition for nonalcoholic fatty liver disease (NAFLD)

a technology for fatty liver disease and composition, applied in the field of novel composition for nonalcoholic fatty liver disease, can solve the problems of increased prevalence of steatohepatitis in non-insulin-dependent diabetes mellitus, weight loss, obesity patients who lost weight before death, etc., and achieve the effect of advanced liver scarring and advanced liver scarring

Inactive Publication Date: 2016-06-16
CADILA HEALTHCARE LTD
View PDF8 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention relates to methods and compositions for treating different forms of chronic liver diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and advanced scarring of the liver (cirrhosis). More specifically, this invention involves the use of a specific compound called Compound A that can reduce inflammation and fibrogenesis in the liver tissue, thereby promoting healing and reducing damage caused by these chronic conditions. This compound has been found to be safe and well tolerated when used at therapeutic doses in humans.

Problems solved by technology

The technical problem addressed in this patent text is the need for a treatment for nonalcoholic fatty liver disease (NAFLD) and particularly nonalcoholic steatohepatitis (NASH). NAFLD and NASH are frequently reported in obese patients and are characterized by fat accumulation, tissue degeneration, inflammation, cell degeneration, fibrosis, and even cirrhosis. Currently, weight loss is the common prescription, but it is difficult to determine the effect of a reduction in weight on NASH because obese patients often do not maintain significant weight reduction. Therefore, there is a need to find a more effective treatment for NAFLD and NASH.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel composition for nonalcoholic fatty liver disease (NAFLD)
  • A novel composition for nonalcoholic fatty liver disease (NAFLD)
  • A novel composition for nonalcoholic fatty liver disease (NAFLD)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019]The present invention describes a pharmaceutical composition for reduction and removal of lipid accumulated in the liver cells (hepatocytes), required for treating and preventing certain diseases and conditions in subject suffering from nonalcoholic fatty liver disease (NAFLD) including fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), and cirrhosis (advanced scarring of the liver) and methods for ameliorating and / or treating such disease conditions.

[0020]The formulation comprises compound of formula (I) and the method comprises administering to a subject in need thereof an effective amount of a compound according to Formula (I), or a pharmaceutically acceptable salt thereof.

wherein ‘R’ is selected from hydroxy, hydroxyalkyl, acyl, alkoxy, alkylthio, thioalkyl, aryloxy, arylthio and M+ represents suitable metal cations such as Na+, K+, Ca+2, Mg+2 and the like.

DEFINITIONS AND ABBREVIATIONS

[0021]As used above, and throughout this disclosure, the following terms, unle...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Massaaaaaaaaaa
Compositionaaaaaaaaaa
Login to View More

Abstract

The present invention provides a compound of Formula (I) or pharmaceutical acceptable thereof, wherein ‘R’ is herein described. In addition, the invention relates to composition comprising effective therapeutic amount of compound of formula (I) and methods of using the compounds for treating or prevention disorder such as nonalcoholic fatty liver disease (NAFLD) including fatty liver (steatosis), nonalcoholic steatohepatitis (NASH), and cirrhosis (advanced scarring of the liver).

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner CADILA HEALTHCARE LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com